← Back to Search

Behavioural Intervention

MomMoodBooster + Phone Coaching for Postpartum Depression (Perinatal MMB Trial)

N/A

Waitlist Available

Led By Emily BK Thomas, PhD

Research Sponsored by University of Iowa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged between 18 and 50 years

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Perinatal MMB Trial Summary

This trial is investigating whether adding weekly phone coaching calls to the MomMoodBooster intervention, an online program for postpartum depression, will be more effective than the online program alone. The MomMoodBooster intervention contains six cognitive-behavioral modules that span six weeks, and it includes identification of pleasant activities, tracking mood and thoughts, and identification of goals.

Who is the study for?

This trial is for pregnant or postpartum veterans aged 18-50 who are experiencing symptoms of depression (PHQ-9 score ≥10). Participants must have internet or smartphone access. It's not suitable for those with a history of mania, psychosis, current hypomania, or active thoughts of suicide.Check my eligibility

What is being tested?

The study tests the MomMoodBooster program, an online cognitive-behavioral therapy intervention for postpartum depression. The trial compares the effectiveness of this program alone versus combined with weekly phone coaching to reinforce skills and goals over six weeks.See study design

What are the potential side effects?

As this is a non-medical intervention focusing on behavioral therapy and support via technology and phone coaching, traditional side effects associated with medications are not expected. However, participants may experience emotional discomfort addressing depressive symptoms.

Perinatal MMB Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 50 years old.

Perinatal MMB Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Behavioral Activation

Change in Depressive Symptoms

Change in Negative Automatic Thoughts

Secondary outcome measures

Change in Anxiety Symptoms

Change in Dyadic Adjustment

Other outcome measures

Program satisfaction

Perinatal MMB Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MomMoodBooster + CoachExperimental Treatment2 Interventions

Group II: MomMoodBooster OnlineActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Phone Coaching

2020

N/A

~240

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

US Department of Veterans AffairsFED

868 Previous Clinical Trials

487,690 Total Patients Enrolled

University of IowaLead Sponsor

446 Previous Clinical Trials

879,302 Total Patients Enrolled

1 Trials studying Postpartum Depression

30 Patients Enrolled for Postpartum Depression

Emily BK Thomas, PhDPrincipal InvestigatorUniversity of Iowa; Rural Health Resource Center - Iowa City

Media Library

MomMoodBooster (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05196152 — N/A

Postpartum Depression Research Study Groups: MomMoodBooster Online, MomMoodBooster + Coach

Postpartum Depression Clinical Trial 2023: MomMoodBooster Highlights & Side Effects. Trial Name: NCT05196152 — N/A

MomMoodBooster (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05196152 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for individuals aged over 55 to participate in this examination?

"As indicated by the criteria for inclusion, this study aims to enrol patients aged 18-50. Additionally, there are 197 studies related to individuals younger than 18 and 969 dedicated to those over 65 years old."

Answered by AI

What is the aggregate figure for volunteers participating in this research?

"Affirmative. Clinicaltrials.gov data confirms that this trial, posted on March 3rd 2022, is actively searching for participants to join in the study. 200 patients are desired from a single medical centre."

Answered by AI

To whom is access to this experiment available?

"This study requires that patients have melancholia, be aged between 18 and 50 years old, to qualify for the trial. 200 total participants are being sought after."

Answered by AI

Are there still slots available to participate in this research endeavor?

"Affirmative. According to clinicaltrials.gov, this investigation is at present recruiting participants. It was first published on the 3rd of March 2022 and its most recent update took place on the 9th of June 2022. 200 patients will be recruited from a single site for this trial."

Answered by AI

Recent research and studies

Journal of Medical Internet ResearchJournal

Mommoodbooster Web-based Intervention for Postpartum Depression: Feasibility Trial Results

Danaher, Brian G, Jeannette Milgrom, John R Seeley, Scott Stuart, Charlene Schembri, Milagra S Tyler, Jennifer Ericksen, et al.. 2013. “Mommoodbooster Web-based Intervention for Postpartum Depression: Feasibility Trial Results”. Journal of Medical Internet Research. JMIR Publications Inc.. doi:10.2196/jmir.2876.

Obstetrics and Gynecology Clinics of North AmericaJournal

Postpartum Depression

Kroska, Emily B., and Zachary N. Stowe. 2020. “Postpartum Depression”. Obstetrics and Gynecology Clinics of North America. Elsevier BV. doi:10.1016/j.ogc.2020.05.001.

AssessmentJournal

Development and Validation of New Anxiety and Bipolar Symptom Scales for an Expanded Version of the IDAS (the IDAS-II)

Watson, David, Michael W. O’Hara, Kristin Naragon-Gainey, Erin Koffel, Michael Chmielewski, Roman Kotov, Sara M. Stasik, and Camilo J. Ruggero. 2012. “Development and Validation of New Anxiety and Bipolar Symptom Scales for an Expanded Version of the IDAS (the IDAS-II)”. Assessment. SAGE Publications. doi:10.1177/1073191112449857.

Comprehensive PsychiatryJournal